(Q87664325)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25158999%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

title

Management of hepatocellular carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25158999%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

author name string

P Fitzmorris

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25158999%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

M Shoreibah

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25158999%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

B S Anand

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25158999%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

A K Singal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25158999%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

publication date

27 August 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25158999%20AND%20SRC:MED&resulttype=core&format=json

Journal of Cancer Research and Clinical Oncology

13 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25158999%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

volume

141

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25158999%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25158999%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

page(s)

861-876

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25158999%20AND%20SRC:MED&resulttype=core&format=json

Medical treatment of unresectable hepatocellular carcinoma: Going beyond sorafenib

13 March 2020

cites work

1 reference

12 December 2020

Brivanib in patients with advanced hepatocellular carcinoma who were intolerant to sorafenib or for whom sorafenib failed: results from the randomized phase III BRISK-PS study.

1 reference

12 December 2020

Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies

1 reference

12 December 2020

Management of hepatocellular carcinoma: An update

1 reference

12 December 2020

Diagnosis of intrahepatic metastasis and multicentric carcinogenesis by microsatellite loss of heterozygosity in patients with multiple and recurrent hepatocellular carcinomas.

1 reference

12 December 2020

Regorafenib as second-line therapy for intermediate or advanced hepatocellular carcinoma: multicentre, open-label, phase II safety study

1 reference

12 December 2020

Use of tamoxifen in advanced-stage hepatocellular carcinoma. A systematic review.

1 reference

12 December 2020

Focus on dysplastic nodules and early hepatocellular carcinoma: an Eastern point of view

1 reference

12 December 2020

Complications after percutaneous saline-enhanced radiofrequency ablation of liver tumors: 3-year experience with 336 patients at a single center

1 reference

12 December 2020

Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States

1 reference

12 December 2020

Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: Model of End-Stage Liver Disease (MELD) score predicts perioperative mortality

1 reference

12 December 2020

Hepatocellular carcinoma patients are advantaged in the current liver transplant allocation system

1 reference

12 December 2020

Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.

1 reference

12 December 2020

Hepatocellular carcinoma

1 reference

12 December 2020

Clinical trials in primary hepatocellular carcinoma: current status and future directions

1 reference

12 December 2020

Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study

1 reference

12 December 2020

Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure.

1 reference

12 December 2020

Can the dropout risk of candidates with hepatocellular carcinoma predict survival after liver transplantation?

1 reference

12 December 2020

Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma

1 reference

12 December 2020

Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience).

1 reference

12 December 2020

Surveillance for hepatocellular cancer with ultrasonography vs. computed tomography -- a randomised study

1 reference

12 December 2020

Needle track seeding following biopsy of liver lesions in the diagnosis of hepatocellular cancer: a systematic review and meta-analysis

1 reference

12 December 2020

Model for end-stage liver disease (MELD) score, as a prognostic factor for post-operative morbidity and mortality in cirrhotic patients, undergoing hepatectomy for hepatocellular carcinoma

1 reference

12 December 2020

High pathological risk of recurrence after surgical resection for hepatocellular carcinoma: an indication for salvage liver transplantation.

1 reference

12 December 2020

A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers

1 reference

12 December 2020

Transarterial embolization for hepatocellular carcinoma. Antibiotic prophylaxis and clinical meaning of postembolization fever.

1 reference

12 December 2020

Conditional survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients

1 reference

12 December 2020

Prognostic prediction and treatment strategy in hepatocellular carcinoma.

1 reference

12 December 2020

Combination of radiofrequency ablation with transarterial chemoembolization for hepatocellular carcinoma: a meta-analysis

1 reference

12 December 2020

A 6-month versus a 12-month surveillance for hepatocellular carcinoma in 559 hemophiliacs infected with the hepatitis C virus

1 reference

12 December 2020

Resection of hepatocellular carcinoma without preoperative tumor biopsy

1 reference

12 December 2020

A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma

1 reference

12 December 2020

AFP-producing gastric carcinoma: multivariate analysis of prognostic factors in 270 patients

1 reference

12 December 2020

Adult-to-adult transplantation of the right hepatic lobe from a living donor

1 reference

12 December 2020

Laparoscopic resection of the liver for cancer

1 reference

12 December 2020

Liver transplantation for hepatocellular carcinoma: impact of the MELD allocation system and predictors of survival

1 reference

12 December 2020

Global cancer statistics, 2002

1 reference

12 December 2020

Mortality and morbidity of hepatectomy, radiofrequency ablation, and embolization for hepatocellular carcinoma: a national survey of 54,145 patients.

1 reference

12 December 2020

Sirolimus-based immunosuppression in liver transplantation for hepatocellular carcinoma: a meta-analysis

1 reference

12 December 2020

Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: a prospective study

1 reference

12 December 2020

Importance of low preoperative platelet count in selecting patients for resection of hepatocellular carcinoma: a multi-institutional analysis

1 reference

12 December 2020

Surveillance for hepatocellular carcinoma: in whom and how?

1 reference

12 December 2020

High-dose tamoxifen in the treatment of inoperable hepatocellular carcinoma: A multicenter randomized controlled trial

1 reference

12 December 2020

Sorafenib in advanced hepatocellular carcinoma

1 reference

12 December 2020

Novel advancements in the management of hepatocellular carcinoma in 2008.

1 reference

12 December 2020

Brivanib versus sorafenib as first-line therapy in patients with unresectable, advanced hepatocellular carcinoma: results from the randomized phase III BRISK-FL study

1 reference

12 December 2020

Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States

1 reference

12 December 2020

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

1 reference

12 December 2020

A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma.

1 reference

12 December 2020

Chemoembolization for hepatocellular carcinoma

1 reference

12 December 2020

Simplified staging for hepatocellular carcinoma

1 reference

12 December 2020

Incidence rates of hepatocellular carcinoma in the U.S. and Denmark: recent trends.

1 reference

12 December 2020

Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis.

1 reference

12 December 2020

Transarterial chemoembolization of unresectable hepatocellular carcinoma with drug eluting beads: results of an open-label study of 62 patients

1 reference

12 December 2020

Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list

1 reference

12 December 2020

Lack of response after initial chemoembolization for hepatocellular carcinoma: does it predict failure of subsequent treatment?

1 reference

12 December 2020

Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma

1 reference

12 December 2020

Epidemiology of hepatocellular carcinoma

1 reference

12 December 2020

Effectiveness of MR imaging in characterizing small hepatic lesions: routine versus expert interpretation.

1 reference

12 December 2020

Doxorubicin-eluting beads versus conventional transarterial chemoembolization for the treatment of hepatocellular carcinoma

1 reference

12 December 2020

Transarterial chemoembolization (TACE) plus sorafenib versus TACE for intermediate or advanced stage hepatocellular carcinoma: a meta-analysis

1 reference

12 December 2020

Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasiveness

1 reference

12 December 2020

The meaning of life expectancy: what is a clinically significant gain?

1 reference

12 December 2020

Treatment of hepatocellular carcinoma with combined suppression and inhibition of sex hormones: a randomized, controlled trial

1 reference

12 December 2020

Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation

1 reference

12 December 2020

MELD Exceptions and Rates of Waiting List Outcomes.

1 reference

12 December 2020

Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma

1 reference

12 December 2020

Lamivudine for patients with chronic hepatitis B and advanced liver disease

1 reference

12 December 2020

Mammalian target of rapamycin inhibitors are associated with lower rates of hepatocellular carcinoma recurrence after liver transplantation: a systematic review.

1 reference

12 December 2020

Liver transplantation for hepatocellular cancer: the impact of the MELD allocation policy

1 reference

12 December 2020

A model for dropout assessment of candidates with or without hepatocellular carcinoma on a common liver transplant waiting list

1 reference

12 December 2020

Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy.

1 reference

12 December 2020

Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trial

1 reference

12 December 2020

Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma.

1 reference

12 December 2020

Recurrence of hepatocellular carcinoma following liver transplantation: a review of preoperative and postoperative prognostic indicators

1 reference

12 December 2020

Risk for hepatocellular carcinoma in patients with alcoholic cirrhosis: a Danish nationwide cohort study

1 reference

12 December 2020

Hepatocellular carcinoma screening in patients waiting for liver transplantation: a decision analytic model

1 reference

12 December 2020

Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report

1 reference

12 December 2020

Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis.

1 reference

12 December 2020

Yttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: A phase 2 study

1 reference

12 December 2020

Increased Quality of Life Among Hepatocellular Carcinoma Patients Treated With Radioembolization, Compared With Chemoembolization

1 reference

12 December 2020

Selection Criteria for Repeat Hepatectomy in Patients With Recurrent Hepatocellular Carcinoma

1 reference

12 December 2020

Hepatocellular carcinoma: recent trends in the United States

1 reference

12 December 2020

Earlier presentation and application of curative treatments in hepatocellular carcinoma.

1 reference

12 December 2020

The model for end-stage liver disease based cancer staging systems are better prognostic models for hepatocellular carcinoma: a prospective sequential survey

1 reference

12 December 2020

Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics.

1 reference

12 December 2020

Association between nucleoside analogues and risk of hepatitis B virus–related hepatocellular carcinoma recurrence following liver resection

1 reference

12 December 2020

The added value of quality of life (QoL) for prognosis of overall survival in patients with palliative hepatocellular carcinoma.

1 reference

12 December 2020

Cost-effectiveness of screening for detection of small hepatocellular carcinoma in western patients with Child-Pugh class A cirrhosis

1 reference

12 December 2020

Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials

1 reference

12 December 2020

A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma

1 reference

12 December 2020

Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice?

1 reference

12 December 2020

Randomized controlled trial of screening for hepatocellular carcinoma

1 reference

12 December 2020

Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes

1 reference

12 December 2020

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

1 reference

12 December 2020

Meta-analysis of surgical resection and radiofrequency ablation for early hepatocellular carcinoma

1 reference

12 December 2020

Hepatocellular carcinoma in 2011 and beyond: from the pathogenesis to molecular targeted therapy

1 reference

12 December 2020

Liver abscess formation after hepatic chemoembolization for metastatic pancreatic neuroendocrine tumor

1 reference

12 December 2020

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

1 reference

12 December 2020

Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review

1 reference

12 December 2020

Randomized controlled trial for hepatocellular carcinoma with portal vein thrombosis: intra-arterial iodine-131-iodized oil versus medical support

1 reference

12 December 2020

Local ablation therapy for hepatocellular carcinoma

1 reference

12 December 2020

Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients

1 reference

12 December 2020

A systematic review of sorafenib in Child-Pugh A patients with unresectable hepatocellular carcinoma

1 reference

12 December 2020

Factors linked to early recurrence of small hepatocellular carcinoma after hepatectomy: Univariate and multivariate analyses

1 reference

12 December 2020

Meta-analysis: interferon improves outcomes following ablation or resection of hepatocellular carcinoma

1 reference

12 December 2020

Indication of the extent of hepatectomy for hepatocellular carcinoma on cirrhosis by a simple algorithm based on preoperative variables.

1 reference

12 December 2020

Sirolimus-based immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinoma.

1 reference

12 December 2020

Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis

1 reference

12 December 2020

Hepatocellular carcinoma: an epidemiologic view

1 reference

12 December 2020

Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis

1 reference

12 December 2020

Diagnosis of hepatocellular carcinoma: newer radiological tools

1 reference

12 December 2020

Liver abscess formation after transarterial chemoembolization for malignant hepatic tumor

1 reference

12 December 2020

Implications of worse renal dysfunction and medical comorbidities in patients with NASH undergoing liver transplant evaluation: impact on MELD and more

1 reference

12 December 2020

Hepatocellular carcinoma

1 reference

12 December 2020

Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients

1 reference

12 December 2020

Living donor liver transplantation for early hepatocellular carcinoma: A life-expectancy and cost-effectiveness perspective

1 reference

12 December 2020

Systematic review of outcomes of liver resection for early hepatocellular carcinoma within the Milan criteria

1 reference

12 December 2020

Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status.

1 reference

12 December 2020

Doxorubicin-eluting bead vs conventional transcatheter arterial chemoembolization for hepatocellular carcinoma before liver transplantation.

1 reference

12 December 2020

Design and endpoints of clinical trials in hepatocellular carcinoma.

1 reference

12 December 2020

Predicting morbidity and mortality after hepatic resection in patients with hepatocellular carcinoma: the role of Model for End-Stage Liver Disease score.

1 reference

12 December 2020

Ductular reaction is helpful in defining early stromal invasion, small hepatocellular carcinomas, and dysplastic nodules.

1 reference

12 December 2020

A prospective randomized trial of the preventive effect of pre-operative transcatheter arterial embolization against recurrence of hepatocellular carcinoma.

1 reference

12 December 2020

[AFP-producing intestinal cancer]

1 reference

12 December 2020

Radiofrequency thermal ablation vs. percutaneous ethanol injection for small hepatocellular carcinoma in cirrhosis: meta-analysis of randomized controlled trials.

1 reference

12 December 2020

Antiviral therapy reduces risk of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis

1 reference

12 December 2020

10.1007/S00432-014-1806-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25158999%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

1 reference